What Behavioral Health DSOs Need to Have Ready Before a PE Conversation

Who This Is For

You’re running a behavioral health group — multiple locations, multiple providers, growing revenue. You’ve had inbound calls from PE firms or you’re planning to initiate a process in the next 12–24 months. You know the conversation is coming and you want to walk in prepared.

This guide covers what PE firms actually scrutinize in behavioral health DSO transactions, what separates a premium multiple from a mid-range offer, and what most operators don’t have ready that costs them both money and time in diligence.

It is written for founders and CEOs who understand their business but may not have been through a PE transaction before, and for COOs and CFOs who will own the diligence process once it starts.

The Behavioral Health PE Landscape in 2026

Private equity investment in behavioral health has matured significantly. The early-stage consolidation plays — acquire practices, cut costs, roll up — have given way to a more sophisticated buyer who understands that behavioral health DSOs face specific risks: regulatory exposure, provider dependency, payer concentration, and an industry-wide shift toward value-based reimbursement that will change margin structures over the next decade.

The buyers in the market today are not just financial engineers. They’re asking clinical questions, reimbursement questions, and workforce questions that operators weren’t asked five years ago. If you walk into a PE conversation prepared to answer only the financial questions, you will leave money on the table.

EBITDA multiples for behavioral health DSOs currently range from roughly 6x to 10x+ depending on size, growth profile, operational maturity, and clinical defensibility. The gap between a 6x and a 9x offer on the same EBITDA is entirely attributable to how the buyer assesses risk. Your job in the pre-diligence period is to reduce every category of perceived risk before the formal process begins.

Part 1 — Financial Readiness

This is the floor. Every PE firm will dig into your financials in the first two weeks of diligence. If the numbers aren’t clean, the process stalls or the offer gets re-cut.

What They Want to See

24–36 months of monthly financials, clean and consistent. P&L by location, not just consolidated. Revenue by service line (therapy, medication management, TMS, other). Headcount and compensation detail by provider category. If your financials require significant explanation to be understood, they need work before you run a process.

EBITDA with documented add-backs. PE firms will apply their own normalized EBITDA calculation. Come in with your own add-back schedule prepared and defensible. Common legitimate add-backs in behavioral health DSOs:

• Founder compensation above market rate
• Non-recurring legal, consulting, or transaction costs
• One-time facility build-out or relocation costs
• Equity compensation

What will not survive scrutiny as an add-back: recurring operational costs you’ve labeled non-recurring, costs that will reoccur post-transaction, and anything that inflates EBITDA in a way that doesn’t reflect ongoing business performance. Be conservative — you’ll have more credibility in negotiation.

Revenue by payer, broken out. Medicare, Medicaid, commercial (by plan if possible), self-pay, out-of-pocket. More than 40% of revenue from any single payer is a concentration flag. Heavy Medicaid exposure gets scrutinized for state rate cut risk.

RCM metrics — the numbers most operators can’t produce cleanly. This is where most behavioral health DSO processes slow down. PE firms want:

• Net collection rate by service line and payer. Industry benchmark is 95–98%. Below 92% triggers questions.
• Days in A/R — 30–35 days is strong. Over 50 starts conversations about whether collections are being managed proactively.
• Denial rate and clean claim rate — first-pass denial rate above 10% is a billing ops flag.
• Charge capture rate — what percentage of completed visits generated a billed claim.
• Average days to bill — time from service date to claim submission. Over 7 days for routine visits raises questions.

If you can’t produce these metrics cleanly, start building them now. PE firms will model your business using these numbers and any gaps they fill in themselves — conservatively.

Red Flags That Kill Multiples

Revenue concentration. One location generating more than 30% of total revenue. One provider generating more than 20% of revenue. One payer covering more than 40% of claims. Any of these creates a single-point-of-failure narrative that PE will price heavily into the risk discount.

Inconsistent month-to-month revenue. Unexplained lumps, dips, or one-time items that haven’t been clearly documented. The less they have to normalize, the more they trust the EBITDA.

Accounts receivable aging problems. Large balances in the 90+ day bucket are both a valuation concern and an operational concern. Clean your AR before you run a process. Write off what’s uncollectable.

Part 2 — Clinical and Operational Readiness

PE firms doing behavioral health deals now have clinical advisors. They will ask clinical questions in diligence.

Outcomes Data

This is the category where most behavioral health DSOs are unprepared — and where you have the opportunity to differentiate significantly.

PE buyers are increasingly aware that value-based reimbursement is coming to behavioral health. The CMS Innovation in Behavioral Health Model launched in 2025. Commercial payers are expanding outcome-based arrangements. A DSO that enters a PE conversation with no outcomes data is implicitly saying: we don’t know if our clinical program works, and we have no protection if payer reimbursement shifts from volume to value.

A DSO that enters with five years of longitudinal PHQ-9 data, documented response and remission rates by service line, and correlation between outcomes and RCM performance is saying something entirely different: our revenue is clinically defensible, and we are positioned for the reimbursement environment that is coming.

What to have ready:

• PHQ-9 response rate and remission rate by service line (therapy, medication management, TMS)
• Measurement compliance rate — what percentage of patients have baseline and follow-up scores
• Response and remission by payer — shows you understand your population mix
• Session completion rates — what percentage of patients complete a full treatment course
• Any published or publishable outcomes data you can reference

If you have this data, put it in a one-page clinical outcomes summary and include it in your management presentation. It is not standard in behavioral health DSO processes — which is exactly why it stands out.

Provider Workforce

Provider dependency is one of the top risk factors PE assigns in behavioral health transactions:

• What happens to revenue if your top-producing psychiatrist leaves?
• Are providers on employment agreements with non-competes?
• What is your provider turnover rate over the last 24 months?
• How long does it take to credential and onboard a new provider?
• Do you have an associate-level pipeline or are you dependent on fully licensed providers?

What to have ready:

• Employment agreement templates with non-solicitation and non-compete provisions reviewed by counsel
• Provider productivity data by individual — visits per day, RVUs, revenue attribution
• Credentialing timelines by payer
• Turnover data and exit interview themes if available
• Employed vs. contractor analysis — PE strongly prefers employed providers

Scalability of Systems

PE is buying a platform, not a practice. They need to believe that adding 5 locations doesn’t require adding 5 full back-office teams.

What to have ready:

• Technology stack documentation — EHR, billing system, scheduling, outcomes measurement, HR
• Org chart showing which functions are centralized vs. location-level
• Standard operating procedures for credentialing, billing, intake, and clinical documentation
• Any locations opened in the last 24 months and how long they took to reach breakeven

Part 3 — The Management Presentation

The management presentation sets the narrative. A weak CIM can kill a process before it starts.

What Goes In

The business overview: What you do, who you serve, how many locations, how many providers, what service lines.

The market opportunity: Why behavioral health, why now, why your geography. Referral sources, competitive landscape, payer dynamics.

The financial story: Revenue and EBITDA trending 24–36 months. Growth rate. EBITDA margin progression. New location ramp model. Forward projections with assumptions clearly stated.

The clinical story: This is what most behavioral health DSOs skip. A one-page outcomes summary showing PHQ-9 response rates, remission rates, and measurement consistency tells PE that your clinical model is reproducible and defensible.

The management team: Who runs what. Depth below the founder. PE is assessing whether the business can operate without you.

The growth plan: Be specific. “We plan to open 10 locations” is not a plan. “We have signed LOIs in two markets, a real estate pipeline in three others, and a playbook that takes new locations from lease signing to first patient in 90 days” is a plan.

What Most Operators Get Wrong

They lead with revenue and bury clinical operations. PE buyers in behavioral health now think about clinical risk as a proxy for regulatory and reimbursement risk. Lead with your clinical model.

They present projections without a bottoms-up model. “We’ll grow 30% per year” with no location-level model gets discounted heavily.

They don’t address the risks. Presenting a risk section with your mitigation narrative is more credible than presenting only upside.

Part 4 — Due Diligence Preparation

Once you’re in a process, diligence will run 60–90 days and touch every part of your business.

The Data Room

Organize it before the process starts. Standard sections:

Financial: 3 years of audited financials, monthly P&Ls by location (trailing 36 months), AR aging, billing system exports (NCR, denial rate, days to bill, charge capture — trailing 24 months), cap table, debt and lease obligations.

Legal: Corporate structure, real property leases, provider employment agreements, payer contracts, pending litigation, compliance documentation.

Clinical / Regulatory: State licensure per location, provider licenses and credentialing files, HIPAA compliance and BAA inventory, OIG or Medicaid audit history, outcomes data and methodology.

Human Resources: Org chart, compensation by role, turnover data (trailing 24 months), benefits summary.

Technology: System contracts, EHR and billing documentation, data security or breach history.

The Questions That Catch Operators Off Guard

“Walk us through your clinical documentation standards and how you audit compliance.” — They’re looking for documentation risk.

“What percentage of your TMS cases have prior authorization on file before the first session?” — TMS auth rates are a revenue risk.

“Show us your credentialing timeline by payer for the last three new providers you hired.” — Long credentialing gaps are uncaptured revenue.

“What happens to revenue at Location X if Dr. Y leaves?” — Provider dependency.

“How do you measure whether your clinical program is working?” — If your answer is “we don’t systematically measure it,” that’s a risk they’ll price in.

Part 5 — Valuation Drivers and Detractors

What Drives the Multiple Up

• Consistent same-store revenue growth — not just new location growth
• Clean, commercial payer mix — above-Medicaid rates with no single-payer concentration
• Documented outcomes data — PHQ-9 tracking, response and remission rates. Tells PE the clinical model is defensible under VBC.
• Scalable back-office — centralized billing, credentialing, HR
• Provider workforce depth — no single provider generating more than 15–20% of revenue
• Geographic diversification — multiple markets
• Visible new location pipeline — signed LOIs, demonstrated playbook

What Drives the Multiple Down

• Heavy Medicaid concentration — every point above 40% gets discounted
• High denial and re-billing rates — billing ops risk
• Provider concentration — the “key man” problem
• No outcomes data — clinical program not measurable, not defensible under VBC
• Single-market concentration — regulatory risk
• Founder dependency — PE is buying a job, not a platform
• Long credentialing gaps — operational immaturity

Suggested Timeline: 18 Months Before a Process

18–12 months out

• Engage a healthcare-focused M&A attorney to review corporate structure and employment agreements
• Begin or accelerate systematic outcomes measurement across all locations
• Clean up billing or documentation issues
• Build location-level P&L reporting

12–6 months out

• Engage a financial advisor or investment banker experienced in behavioral health
• Compile 36-month financial history in diligence-ready format
• Run your own quality of earnings analysis
• Build the outcomes data package: response rates, remission rates, measurement compliance

6 months out

• Draft management presentation
• Organize data room
• Prepare leadership team for management meetings
• Define valuation expectations based on comparable transactions

---

Related reading:

• What PE Firms Miss in Behavioral Health Due Diligence — the operational intelligence layer most diligence skips
• Psychiatry Outcomes Benchmarks — the PHQ-9 benchmarks to include in your clinical summary
• How to Prepare for a Value-Based Behavioral Health Contract — the VBC readiness that PE buyers are looking for
• 5 Metrics Every Behavioral Health CEO Should Track Weekly — the operational metrics PE will ask about

This guide is intended for informational purposes and does not constitute legal, financial, or investment advice. Consult qualified advisors before entering any transaction process.